- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
Since arriving on the island of Guam in the 1940s, the brown tree snake ( Boiga irregularis ) has extirpated native...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Scientists Grow Human Livers in Mice
3 July 2013 1:57 pm
TOKYO—A Japanese group has generated functional human livers by creating liver precursor cells in the laboratory and then transplanting them into mice to complete the developmental process. Their ultimate goal is to transplant the precursor cells into humans and let them develop into replacements for diseased or damaged organs.
The achievement represents a new direction in the use of human pluripotent stem cells, which have the potential to develop into any of the tissues of the human body. So-called induced pluripotent stem (iPS) cells, which are derived from adult human tissue, have the added advantage of producing tissues and organs genetically matched to a recipient, avoiding the problem of immune system rejection. But creating fully mature human tissue in a petri dish (in vitro) has proved a daunting challenge, especially when it comes to producing 3D organs.
Rather than do it all in a dish, the group decided to try starting the process in vitro but completing it in an animal (in vivo). They tried hundreds of different recipes; eventually they discovered that if they mixed liver precursor cells (derived from iPS cells) with two other types of standard human cell lines known to be important for embryonic liver development, then the cells would spontaneously form a 4 to 5-millimeter 3D structure called a liver bud. "This worked beyond our expectations, though the mechanism is not entirely clear," says group leader and stem cell scientist Takanori Takebe of Yokohama City University in Japan.
Next, they implanted these buds in mice with disabled immune systems to see if they would engraft, or attach to the blood vessels of the animal, and continue to mature. They did: The transplanted liver buds developed into what Takebe calls "miniature livers." The team then confirmed that these tiny organs produced proteins typically made by human livers, and they properly processed certain drugs that mouse livers cannot handle. This "proof of concept demonstration" provides a promising new approach to regenerative medicine, the team writes in a paper published online by Nature today.
The experiment shows that precursor cells can develop into functional organs when placed within the body of an adult mammal, says Takebe, who hopes to use the technique to grow organs in nonhuman primates and eventually in humans. He believes it could be applied to other organs, such as kidneys or pancreases, as well.
Stem cell scientist Martin Pera of the University of Melbourne in Australia, calls it an "exciting study" that demonstrates that the environment within an adult body can help immature stem cells develop to an adult stage, something that has proven difficult to do in vitro. The report "provides hope that even primitive tissues made from stem cells will one day restore the function of dead or diseased organs in patients," he adds.
But there are significant hurdles to clear before the technique reaches the clinic. In addition to passing all the safety checks needed to gain approval for human use, there is a practical problem. Takebe says they will need to transplant huge numbers of liver buds, comprising billions or trillions of the human iPS-derived precursor cells to even partially replace a human liver. Producing cells in those numbers will require a breakthrough in automated cell proliferation. Because of that, Takebe says use in humans is at least a decade away.